Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nilsson

Showing results (371-380 of 1,735) with videos related to

Pageof 174
Sort By:
British Medical Journal (Clinical Research Ed.)|May 18, 1985
Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitorI M Nilsson, H Ljungnér, L Tengborn
British Medical Journal|September 25, 1976
Effect of ethyloestrenol on fibrinolysis in the vessel wallU Hedner, I M Nilsson, S Isacson
The Journal of Laboratory and Clinical Medicine|March 1, 1971
Quantitative determination of platelet fibrinogenM Karaca, I M Nilsson, U Hedner
Acta Medica Scandinavica|October 1, 1971
Clinical experience with a Swedish factor IX concentrateI M Nilsson, A Ahlberg, G Björlin
Annals of Internal Medicine|January 1, 1973
Suppression of factor IX antibody in hemophilia B by factor IX and cyclophosphamideI M Nilsson, U Hedner, G Björlin
Acta Chirurgica Scandinavica|January 1, 1974
The fibrinolytic system and postoperative thrombosis following operation of rectal carcinoma. A preliminary reportM Aberg, S Isacson, I M Nilsson
Scandinavian Journal of Infectious Diseases|January 1, 1974
The occurrence and significance of fibrin-fibrinogen degradation products (FDP) in acute infectionsP Skånsberg, S Cronberg, I M Nilsson
Acta Paediatrica Scandinavica|September 1, 1973
Fibrinolysis in lymphangiomaR Kornfält, I M Nilsson, L Okmian
Lakartidningen|March 30, 2026
Peter M Nilsson, Miriam Pikkemaat, Ulrika Andersson
Lakartidningen|July 2, 2013
[Hypertension is the greatest threat to global health. Increases the risk of cardiovascular disease, dementia and kidney disease]Thomas Kahan, Bo Carlberg, Peter M Nilsson
Pageof 174

Showing results (371-380 of 1,735) with videos related to

Sort By:
Pageof 174
British Medical Journal (Clinical Research Ed.)|May 18, 1985
Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitorI M Nilsson, H Ljungnér, L Tengborn
British Medical Journal|September 25, 1976
Effect of ethyloestrenol on fibrinolysis in the vessel wallU Hedner, I M Nilsson, S Isacson
The Journal of Laboratory and Clinical Medicine|March 1, 1971
Quantitative determination of platelet fibrinogenM Karaca, I M Nilsson, U Hedner
Acta Medica Scandinavica|October 1, 1971
Clinical experience with a Swedish factor IX concentrateI M Nilsson, A Ahlberg, G Björlin
Annals of Internal Medicine|January 1, 1973
Suppression of factor IX antibody in hemophilia B by factor IX and cyclophosphamideI M Nilsson, U Hedner, G Björlin
Acta Chirurgica Scandinavica|January 1, 1974
The fibrinolytic system and postoperative thrombosis following operation of rectal carcinoma. A preliminary reportM Aberg, S Isacson, I M Nilsson
Scandinavian Journal of Infectious Diseases|January 1, 1974
The occurrence and significance of fibrin-fibrinogen degradation products (FDP) in acute infectionsP Skånsberg, S Cronberg, I M Nilsson
Acta Paediatrica Scandinavica|September 1, 1973
Fibrinolysis in lymphangiomaR Kornfält, I M Nilsson, L Okmian
Lakartidningen|March 30, 2026
Peter M Nilsson, Miriam Pikkemaat, Ulrika Andersson
Lakartidningen|July 2, 2013
[Hypertension is the greatest threat to global health. Increases the risk of cardiovascular disease, dementia and kidney disease]Thomas Kahan, Bo Carlberg, Peter M Nilsson
Pageof 174